TABLE Of CONTENT:
1. How much Covid?
2. Missing pieces: Known unknowns in epidemiologic methods
3. Longitudinal effects of lipid indices on incident cardiovascular diseases adjusting for time-varying confounding using marginal structural models: 25 years follow-up of two US cohort studies
4. Evolving mortality and clinical outcomes of hospitalized subjects during successive COVID-19 waves in Catalonia, Spain
5. Accuracy of fatal occupational injury registration in a high-income country: A comparison of two-source capture-recapture estimates with the number of cases identified in four register systems in Norway, 2000–2003
6. Long-term air pollution exposure and incident stroke in American older adults: A national cohort study
7. Vaccine effectiveness and duration of protection against symptomatic infections and severe Covid-19 outcomes in adults aged 50 years and over, France, January to mid-December 2021
8. Alcohol consumption and incidence of pancreatic cancer
9. Exposure-response analysis of the association of maternal smoking and use of electronic cigarettes (vaping) in relation to preterm birth and small-for-gestational-age in a national US sample, 2016–2018
10. Relapse-free survival in Sudanese women with non-metastatic breast cancer
11. Modelling the impact of school reopening and contact tracing strategies on Covid-19 dynamics in different epidemiologic settings in Brazil
12. COVID-19 in people aged 18–64 in Sweden in the first year of the pandemic: Key factors for severe disease and death
13. Can you lock down in a slum? And who would benefit if you tried? Difficult questions about epidemiology's commitment to global health inequalities during Covid-19
14. Who is responsible for global health inequalities after Covid-19?
15. Blame or reflection? Response to Winsberg
16. A practical guide to handling competing events in etiologic time-to-event studies
17. P-value, compatibility, and S-value
18. Considerations towards the better integration of epidemiology into quantitative risk assessment
19. Commentary: Systematic reviews and observational epidemiology: The more things change…
20. Commentary: Quantifying the impact of bias to inform quality assessments in systematic reviews: The case of perchloroethylene and Non-Hodgkin's lymphoma
21. Commentary on Methodologic choices in synthesizing epidemiologic evidence to assess perchloroethylene and non-Hodgkin's lymphoma
22. Commentary: On the reliability of causal claims
23. Response: Alternative approaches for systematic review
24. Lost in the woods: Finding our way back to the scientific method in systematic review
25. Systematic review of perchloroethylene and non-Hodgkin's lymphoma